Birdwatch Note Rating
2024-05-06 12:47:03 UTC - HELPFUL
Rated by Participant: B04FA132E9A5A14DFCC6BC8DBB70E79499C87B199E89983BDAE477AEE0757F62
Participant Details
Original Note:
The revocation was made at the request of AstraZeneca itself: "At the holder's request, the marketing authorisation granted by Decision C(2021) 698(final) of 29 January 2021 for the medicinal product "Vaxzevria - COVID-19 Vaccine (ChAdOx1-S [recombinant])" is withdrawn." https://ec.europa.eu/health/documents/community-register/2024/20240327162288/dec_162288_en.pdf
All Note Details